Raynaud's Phenomenom Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
Condition: Raynaud's Phenomenon Secondary to Connective Tissue DiseaseInterventions: Drug: Vascana (0.9% nitroglycerin cream); Drug: Vehicle (placebo)Sponsor: Covis Pharma S.à.r.l.Not yet recruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2016 Category: Research Source Type: clinical trials
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Condition: Raynaud's DiseaseInterventions: Other: placebo; Dietary Supplement: diosmiplexSponsor: Primus PharmaceuticalsRecruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2016 Category: Research Source Type: clinical trials